Carlsbad, California
United States
209
2026-06-04
The entities that hold a legal rights for patent applications filed by inventor Bennett C. Frank:
C. Frank Bennett from Carlsbad, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Compositions for Modulating C9ORF72 Expression
#2 | 2025-07-10Selective Reduction of Allelic Variants
#3 | 2024-09-19Selective Reduction of Allelic Variants
#4 | 2024-07-18COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
#5 | 2024-06-20Compositions for Modulating C9ORF72 Expression
#6 | 2023-06-15Compositions and Methods for Modulation of SMN2 Splicing in a Subject
#7 | 2023-06-08Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression
#8 | 2023-05-25MODIFIED CRISPR RNA AND MODIFIED SINGLE CRISPR RNA AND USES THEREOF
#9 | 2023-04-06METHODS FOR REDUCING HTT EXPRESSION
#10 | 2022-12-22Selective reduction of allelic variants
#11 | 2022-11-24ANTISENSE COMPOUNDS AND USES THEREOF
#12 | 2022-06-23Compositions for modulating Ataxin 2 expression
#13 | 2022-05-12METHODS OF TREATING BREAST CANCER
#14 | 2021-06-10METHODS FOR REDUCING C9ORF72 EXPRESSION
#15 | 2021-05-13Modulation of Huntington expression
#16 | 2021-02-04Compositions and methods for modulation of SMN2 splicing in a subject
#17 | 2021-01-21COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#18 | 2020-12-03Selective Reduction of Allelic Variants
#19 | 2020-12-03COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
#20 | 2020-11-19Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression
#21 | 2020-10-01Combinations for the modulation of SMN expression
#22 | 2020-08-27Modulation of huntingtin expression
#23 | 2020-07-30Compositions and methods for modulation of protein aggregation
#24 | 2020-07-30COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION
#25 | 2020-01-30Compositions and methods for modulation of IKBKAP splicing
#26 | 2020-01-30Methods for treating Alzheimer's disease
#27 | 2019-12-19MODIFIED CRISPR RNA AND USES THEREOF
#28 | 2019-10-24ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF
#29 | 2019-08-15Modulation of huntingtin expression
#30 | 2019-08-15Antisense compounds and uses thereof
#31 | 2019-07-11COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY
#32 | 2019-05-16METHODS FOR REDUCING C9ORF72 EXPRESSION
#33 | 2019-02-28Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#34 | 2019-02-07COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
#35 | 2019-01-31COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
#36 | 2019-01-17Methods for modulating Ataxin 2 expression
#37 | 2019-01-03SELECTIVE REDUCTION OF ALLELIC VARIANTS
#38 | 2018-12-27Compositions and methods for modulation of IKBKAP splicing
#39 | 2018-10-11SELECTIVE REDUCTION OF ALLELIC VARIANTS
#40 | 2018-09-27Compositions and their uses directed to huntingtin
#41 | 2018-09-27Modulation of SMN expression
#42 | 2018-06-28Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
#43 | 2018-06-14MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#44 | 2018-05-10Modulation of nuclear-retained RNA
#45 | 2018-05-10Targeting microRNAs for the treatment of liver cancer
#46 | 2018-03-29Modulation of huntingtin expression
#47 | 2018-01-11Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#48 | 2018-01-04COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS
#49 | 2017-11-23ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF
#50 | 2017-10-05ANTISENSE COMPOUNDS AND USES THEREOF
#51 | 2017-09-21Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#52 | 2017-06-22Compositions for modulating Ataxin 2 expression
#53 | 2017-06-22Methods for modulating Ataxin 2 expression
#54 | 2017-05-18Targeting microRNAS for the treatment of liver cancer
#55 | 2017-02-16Compositions and Methods for Modulation of SMN2 Splicing in a Subject
#56 | 2017-02-09OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS
#57 | 2017-02-09Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#58 | 2017-01-19Compositions and methods for modulation of SMN2 splicing in a subject
#59 | 2016-10-27Modulation of huntingtin expression
#60 | 2016-10-20COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#61 | 2016-07-07Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals
#62 | 2016-03-10Modulation of dystrophia myotonica-protein kinase (DMPK) expression
#63 | 2016-02-25COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#64 | 2016-02-18Targeting microRNAs for the treatment of liver cancer
#65 | 2016-02-04Compositions and methods for modulating Tau expression
#66 | 2016-01-28Methods for monitoring C9ORF72 expression
#67 | 2016-01-21Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#68 | 2016-01-14OLIGOMERIC COMPOUNDS AND EXCIPIENTS
#69 | 2016-01-07Compositions and methods for modulation of SMN2 splicing in a subject
#70 | 2015-12-31Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
#71 | 2015-11-26Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#72 | 2015-11-26Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#73 | 2015-11-19SELECTIVE REDUCTION OF ALLELIC VARIANTS
#74 | 2015-11-12COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS
#75 | 2015-11-05COMPOUNDS AND METHODS FOR IMPROVING CELLULAR UPTAKE OF OLIGOMERIC COMPOUNDS
#76 | 2015-10-15SELECTIVE REDUCTION OF ALLELIC VARIANTS
#77 | 2015-10-15MODULATION OF CD40 EXPRESSION
#78 | 2015-10-01Methods for modulating Tau expression for reducing seizure and modifying a neurodegenerative syndrome
#79 | 2015-09-24Methods for modulating C9ORF72 expression
#80 | 2015-09-17Compositions for modulating C9ORF72 expression
#81 | 2015-06-18Antisense modulation of superoxide dismutase 1, soluble expression
#82 | 2015-06-11Modulation of huntingtin expression
#83 | 2015-04-02OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS
#84 | 2015-01-22COMPOSITIONS AND METHODS FOR MODULATION OF IKBKAP SPLICING
#85 | 2014-12-18Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression
#86 | 2014-12-04COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY
#87 | 2014-11-13Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#88 | 2014-11-06Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#89 | 2014-10-16Compositions and methods for modulation of LMNA expression
#90 | 2014-09-25Compounds and methods for modulating protein expression
#91 | 2014-07-24Targeting microRNAs for the treatment of liver cancer
#92 | 2014-05-01OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS
#93 | 2014-05-01Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#94 | 2014-04-24Antisense compounds targeting genes associated with usher syndrome
#95 | 2014-02-27Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#96 | 2014-01-02Chimeric oligomeric compounds for modulation of splicing
#97 | 2014-01-02Modulation of alpha synuclein expression
#98 | 2013-10-31Compounds and methods for modulating interaction between proteins and target nucleic acids
#99 | 2013-09-12MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#100 | 2013-08-29MODULATION OF NUCLEAR-RETAINED RNA
80084 ⎘